Researchers identify two distinct evotypes of prostate cancer

Prostate cancer, affecting 1 in 8 men, is the most common cancer in men. Researchers have identified two distinct evotypes of adenocarcinoma, the most common type of prostate cancer, using genome sequencing and AI. Patients with one evotype were twice as likely to have a recurrence and metastasis. This finding could lead to tailored treatments and potential drug discoveries. Further research will explore associations with patient factors.